Therapeutic use of botulinum toxin in migraine: mechanisms of action. - Wikidata - thesis-toulmin - TriplyDB

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

http://www.wikidata.org/entity/Q34419654

about

The search for novel analgesics: targets and mechanisms Current status and future directions of botulinum neurotoxins for targeting pain processing Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders Development of onabotulinumtoxinA for chronic migraine Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.OnabotulinumtoxinA for chronic migraine: a critical appraisal.Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt Effective Botulinum Toxin Injection Guide for Treatment of Temporal Headache.Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).Current and Future Issues in the Development of Spinal Agents for the Management of Pain.Anatomical Regional Targeted (ART) BOTOX Injection Technique: A Novel Paradigm for Migraines and Chronic Headaches.Nonparalytic botulinum molecules for the control of pain.Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region.Influence of Onabotulinumtoxin A on testes of the growing rat.Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study.[Modern non-cosmetic treatment with botulinum toxins].OnabotulinumtoxinA in the treatment of refractory chronic cluster headache.Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine.

P2860

Q24288817-47ABFAD3-A508-4CF2-AA7D-D627AF1F9530 Q26778129-BD1DB527-C944-4DD9-A0EC-77F5D5E8331F Q26781281-E3F7C440-3821-41CD-BFA1-26E99E2DD920 Q27027006-43775279-642E-49A5-ABFB-23936702B1AD Q35691221-A5E4A7FD-CD65-474F-BA3D-51931CC11C1A Q35822040-E2A324F2-163B-4421-BF83-8C52225736B1 Q37062762-AE38A1C0-3394-4653-AFA0-9E6B2A6E8276 Q37285681-0D43EB65-1D05-458E-B1ED-3AED76C4E361 Q37686124-23292B5C-D918-48C4-8A63-755256CD93FD Q38406085-84FB8CF1-F337-434A-9494-72CA72EEB6A9 Q38727831-5496F201-B173-463D-9F1F-1E3528455543 Q39158436-E0597672-CEFA-47C4-A03D-A1FCC5ECC5F7 Q40113769-05D92B4E-2F01-4972-B6E8-27F02B065A9E Q42058846-C4ED0F10-3B54-419E-BE62-92DA9E685D4C Q43075742-6A73E1F2-58B0-495D-88E5-CBBBEFE61401 Q44350809-9ECA25EA-6BC2-41CC-80B0-91E19F5A880D Q46471390-368686D0-F283-485C-BAD2-B8B7657FCCB9 Q47408548-5590CF6B-A940-4DEC-8B3B-F2FC1712CC04 Q48556994-6F662AFA-0EFE-459C-9CDE-CEC8CB50E4BA Q55417882-37A3D6DC-F736-48BB-85BB-04C078CAB14A Q55515282-0DE9CCE6-05A7-4E6B-81BA-946E6CEB3447

P2860

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

http://www.wikidata.org/entity/Q34419654

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@ast

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@en

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@nl

type

label

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@ast

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@en

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@nl

prefLabel

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@ast

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@en

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@nl

P1433

Q34419654-C10ED8E0-D2D4-43AC-9013-C0CD87FF5BA5

P1476

Q34419654-9A716432-858C-4B9A-A4A0-DA46862EAAC4

P2093

Q34419654-2E01183E-B1EB-4CA7-9A68-1AA341D1D310

Q34419654-DE252D64-E2D5-4FAA-9D57-83FD2CC84A3B

P2860

Q34419654-0141F68A-11EB-4D36-9E16-5CAE56A31EEE

Q34419654-015532FE-4B29-4BD2-9912-FC8DB964DD70

Q34419654-02BBF51D-D31C-42A3-9983-48FFAD78C90D

Q34419654-036998E7-1BFC-4988-9BCD-093DDF3EA814

Q34419654-05D0C555-B9E1-4EFB-838F-2C44878C8170

Q34419654-05E114CE-A19E-45BB-9CD7-44797B2CB3E7

Q34419654-0664F140-12CB-4B87-98AA-2695E4662E48

Q34419654-0732A994-5BF2-4D43-8B87-A6F3D4D2A4DA

Q34419654-0807F367-2C10-46EB-9294-AF4A80491F5D

Q34419654-0A0FD0A2-BF00-4A3C-96F9-6D45C4785A70

P304

Q34419654-23781E17-4BD3-493A-9367-E788CF7CF280

P31

Q34419654-83D3F622-F841-4605-82C3-D256F6DC92BE

P356

Q34419654-C2AC10F1-E345-41DF-9120-732AD6EDAF01

P407

Q34419654-FCDDC800-60E7-4892-ADAF-9353AA24BD22

P433

Q34419654-32D4BB7E-D9C8-4751-B99B-EE892CAAC152

P478

Q34419654-E575E22F-6E83-4236-BC4C-56EBCEA56436

P577

Q34419654-D70E84E6-7ADB-4ADD-A88B-2020011DCA53

P5875

Q34419654-BEECD190-1036-4ADA-B92A-872B2D0EF1F5

P698

Q34419654-918B6AA3-1E54-4777-BDE1-10CCE8C0DBFA

P921

Q34419654-9D0FFACD-63CF-45EA-A4BE-11F8FB501367

P932

Q34419654-EC7D4703-0C10-4537-8468-45FD067B9313

P356

P1433

British Journal of Pharmacology

P1476

Therapeutic use of botulinum toxin in migraine: mechanisms of action.

@en

P2093

Roshni Ramachandran

http://www.w3.org/2001/XMLSchema#string

Tony L Yaksh

http://www.w3.org/2001/XMLSchema#string

P2860

Postsynaptic complexin controls AMPA receptor exocytosis during LTP

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons

The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin

Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction

Mechanisms of intracellular protein transport

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

Neurogenic inflammation and migraine: implications for the therapeutics

GHRH receptor-targeted botulinum neurotoxin selectively inhibits pulsatile GH secretion in male rats

Regulated delivery of AMPA receptor subunits to the presynaptic membrane.

P304

4177-4192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.12763

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262269705

http://www.w3.org/2001/XMLSchema#string

P698

24819339

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

4241086

http://www.w3.org/2001/XMLSchema#string